What it takes to produce complex OSD drug products from the earliest stages of development to rapid, low-risk tech transfer ...

Evonik, one of the world's leading specialty chemicals companies, is making a significant investment to strengthen manufacturing capabilities at its Tippecanoe Labs site in Lafayette, Indiana. The ...

Meets the growing demand for U.S.-based contract development and manufacturing organizations (CDMOs)Further improves capabilities to handle increasing complexity of active pharmaceutical ingredients ...

Sridevi Khambhampaty, CEO, Shilpa Biologicals Pvt Ltd commented, “The manufacturing of highly potent compounds has been a core pillar of Shilpa’s identity and this ADC drug su ...

After pledging earlier this year to bolster its drug substance capabilities in Central Europe, German chemical company Evonik is turning its attention to the U.S. The company is laying out $100 ...

Eli Lilly has revealed the location of the first of four large-scale manufacturing facilities that it plans to build in the U.S. The company has selected Goochland County, Virginia, as the site of a ...

SHANGHAI, June 24, 2026 /PRNewswire/ -- WuXi Biologics (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), announced that its MFG17 drug substance ...

Shilpa Biologicals Ltd, a subsidiary of Shilpa Medicare Ltd announced the commissioning of a state-of-the-art antibody–drug conjugate (ADC) GMP manufacturing facility, purpose-built and designed to ...